Research burden of interstitial lung diseases in Turkey-RBILD

dc.authorid0000-0002-0697-5680en_US
dc.authorid0000-0002-0891-0020en_US
dc.authorid0000-0003-3746-3095en_US
dc.authorid0000-0002-4692-2639en_US
dc.authorid0000-0001-9603-2231en_US
dc.contributor.authorAyçiçek, Olcay
dc.contributor.authorÇetinkaya, Erdoğan
dc.contributor.authorÜçsular, Fatma Demirci
dc.contributor.authorBayram, Nazan
dc.contributor.authorŞenyiğit, Abdurrahman
dc.contributor.authorAçar, Elif
dc.date.accessioned2023-09-19T07:29:32Z
dc.date.available2023-09-19T07:29:32Z
dc.date.issued2022en_US
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractIntroduction:The aim of our study is to investigate the etiological distribution of ILD in Turkey by stratifying the epidemiological characteristics of ILD cases, and the direct cost of initial diagnosis of the diag-nosed patients. Material-Method: The study was conducted as a multicenter, prospective, cross-sectional, clinical observation study. Patients over the age of 18 and who accepted to participate to the study were included and evaluated as considered to be ILD. The findings of diagnosis, examination and treatment carried out by the cent-ers in accordance with routine diagnostic procedures were recorded observationally. Results: In total,1070 patients were included in this study. 567 (53%) of the patients were male and 503 (47%) were female. The most frequently diagnosed disease was IPF (30.5%). Dyspnea (75.9%) was the highest incidence among the presenting symptoms. Physical examination found bibasilar inspiratory crackles in 56.2 % and radiological findings included reticular opacities and interlobular septal thickenings in 55.9 % of the cases. It was observed that clinical and radiological findings were used most frequently (74.9%) as a diagnostic tool. While the most common treatment approaches were the use of systemic steroids and antifibrotic drugs with a rate of 30.7% and 85.6%, respectively. The total me-dian cost from the patient's admission to diagnosis was 540 Turkish Lira. Conclusion: We believe that our findings compared with data from other countries will be useful in showing the current situation of ILD in our country to discuss this problem and making plans for a solution.en_US
dc.identifier.citationAycicek, O., Cetinkaya, E., Ucsular, F. D., Bayram, N., Senyigit, A., Aksel, N., ... & Ozlu, T. (2022). Research Burden of Interstitial Lung Diseases in Turkey–RBILD. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases, 39(1).en_US
dc.identifier.doi10.36141/svdld.v39i1.12269
dc.identifier.endpage15en_US
dc.identifier.issn1124-0490
dc.identifier.issue1en_US
dc.identifier.pmid35494165en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage1en_US
dc.identifier.urihttp://dx.doi.org/10.36141/svdld.v39i1.12269
dc.identifier.urihttps://hdl.handle.net/20.500.12491/11712
dc.identifier.volume39en_US
dc.identifier.wosWOS:000787870400001en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorAçar, Elif
dc.language.isoenen_US
dc.publisherMattioli 1885en_US
dc.relation.ispartofSarcoidosis Vasculitis and Diffuse Lung Diseasesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectInterstitial Lung Diseaseen_US
dc.subjectLungen_US
dc.subjectIdiopathic Pulmonary Fibrosisen_US
dc.subjectIdiopathic Pulmonary-Fibrosisen_US
dc.subjectClinical Characteristicsen_US
dc.subjectEconomic Burdenen_US
dc.titleResearch burden of interstitial lung diseases in Turkey-RBILDen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
olcay-aycicek.pdf
Boyut:
3.73 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin/Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: